My Cart [ 0 ]
Home > Antibodies > Research-Grade Biosimilars > Lecanemab Biosimilar, Human amyloid-beta Monoclonal Antibody

Lecanemab Biosimilar, Human amyloid-beta Monoclonal Antibody

Lecanemab | APP antibody; ABETA; alpha-sAPP; ABPP

Catalog No. Product Name Size List Price (US$) Quantity
C124P Lecanemab Biosimilar, Human amyloid-beta Monoclonal Antibody 1 mg 175.00
C124P Lecanemab Biosimilar, Human amyloid-beta Monoclonal Antibody 5 mg 480.00
C124P Lecanemab Biosimilar, Human amyloid-beta Monoclonal Antibody 20 mg 1200.00
Description

C124P: Lecanemab Biosimilar, Human amyloid-beta Monoclonal Antibody

Recombinant Humanized IgG1 Monoclonal Antibody. 
Isotype: Human IgG1 kappa.
Source: The anti-human amyloid-beta monoclonal antibody lecanemab biosimilar was produced in mammalian cells.
Specificity/Sensitivity: The in vivo grade lecanemab biosimilar specifically binds to the amyloid-beta protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by lecanemab.
Form of Antibody: 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

Shipping: The research grade lecanemab biosimilar is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70°C as supplied.
1 month from date of receipt, 2 to 8°C as supplied.

Related Links

See our Privacy Policy